Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Merck Gets $2.6 Billion Loan to Replace Facility Due Next Year

Don't Miss Out —
Follow us on:

March 27 (Bloomberg) -- Merck KGaA, Germany’s second-biggest drug maker, raised a 2 billion-euro ($2.6 billion) credit line to replace a loan due next year.

The five-year transaction, which can be extended by as much as two years, was provided by 19 banks, according to a statement from the Darmstadt, Germany-based company. Merck arranged the transaction itself and proceeds will be used for general corporate purposes and growth projects, the company said.

Merck had a credit line due Oct. 2014 that paid an interest margin of 20 basis points more than the euro interbank offered rate, according to data compiled by Bloomberg.

Merck is rated Baa1 by Moody’s Investors Service and A- by Standard & Poor’s.

To contact the reporter on this story: Stephen Morris in London at

To contact the editor responsible for this story: Faris Khan at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.